Doxazosin Tablet
Product Images NDC 50090-8097

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-8097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (C2bacf15 E521 4d06 B4c6 45b40036b73c 01)

Structure (C2bacf15 E521 4d06 B4c6 45b40036b73c 01)
Chemical structure of Doxazosin, including its molecular components and arrangement. The image shows the structural formula with rings, bonds, and functional groups represented in standard chemical notation.*
FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 02)

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 02)
The image shows data tables and a bar graph depicting changes in symptom scores and maximum flow rate (mL/sec) for studies involving Doxazosin compared to placebo. It includes three studies with different doses and treatment durations, illustrating statistically significant mean changes in these parameters for Doxazosin-treated groups versus placebo.*
FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 03)

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 03)
Two line graphs showing clinical trial results of Doxazosin 1 mg oral tablets. The left graph depicts mean change in total symptom score from baseline over 14 weeks, with Doxazosin showing greater symptom score reduction than placebo. The right graph presents mean increase in maximum urinary flow rate from baseline over 14 weeks, indicating higher improvement in the Doxazosin group compared to placebo. Both graphs include error bars and sample sizes.*
FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 04)

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 05)

FDA Label Image

Label Image (Lbl500908097)

Label Image (Lbl500908097)
Doxazosin USP 1 mg oral tablet label from A-S Medication Solutions. The label includes NDC 50090-8097-0, product number 5168-0, lot and expiration date fields. The package contains 30 tablets. Storage instructions indicate keeping the product at 68-77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.